Generic vs brand names: understanding the difference
Every medication has at least 2 names. The generic name (or INN - International Non-proprietary Name) is the standardised scientific name for the active ingredient, assigned through a WHO programme specifically designed to give each substance one unique, globally recognised name and avoid the confusion that costs patient safety. The brand name is the proprietary name the manufacturer uses for marketing. Atorvastatin is the generic; Lipitor is the brand. Same drug, same dose, different price tag.
Why the same drug has multiple brand names
After a drug's patent expires, any manufacturer can produce a generic version under the active ingredient's INN. But they can also brand it under a proprietary name. So atorvastatin might be sold as Lipitor (Pfizer), Atorlip (Cipla), Atocor (Sun Pharma) and dozens of others internationally, all containing the same active ingredient at the same dose. The FDA's Orange Book is the official source confirming which generic and brand versions are therapeutically equivalent. The INN is the constant. The brand name is the variable.
When the generic name appears confusing
Patients sometimes receive a prescription where the brand name is familiar but the generic on the dispensed label is unrecognised. A patient who knows they take Prozac may not recognise fluoxetine on the bottle. This tool solves that immediately. Search either name and get the full picture. For checking whether a generic is safe to substitute in a specific patient, always consult a pharmacist. Some drugs (narrow therapeutic index medications like levothyroxine, warfarin, lithium) may require brand-to-brand consistency. Our Drug Interaction Checker can help assess safety before switching formulations. You can also check the Medication Cost Estimator to compare brand vs generic pricing.
Narrow therapeutic index drugs deserve extra caution
For most medications, switching between brand and generic makes no clinical difference, bioequivalence testing confirms that. A small group of drugs are the exception: warfarin, levothyroxine, lithium, phenytoin and digoxin all have a narrow therapeutic index, meaning the gap between an effective dose and a toxic one is small. Small formulation differences between manufacturers can matter more here, which is why many prescribers ask patients on these drugs to stick with one consistent product rather than switching between generic manufacturers. Several of these NTI drugs are also renally cleared, so a change in kidney function can shift blood levels just as much as a formulation change, our Creatinine Clearance Calculator is worth checking alongside any NTI drug flagged in the results above.